www.fdanews.com/articles/95358-eli-lilly-divests-distaclor-antibiotic
Eli Lilly Divests Distaclor Antibiotic
July 2, 2007
Eli Lilly and Company, the Indian subsidiary of global pharmaceutical major Eli Lilly, has divested one of its premier antibiotic brands in India — Distaclor (Cefaclor) — to Pharmalink, a subsidiary of Quintiles International, for an undisclosed sum.
Business Standard